Rucaparib CAS 283173-50-2

Product Description:

Khoom npe: Rucaparib CAS NO: 283173-50-2

Synonyms:

6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl];

UNII-8237F3U7EH;

8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-ib;

Tshuaj& Lub cev muaj zog:

Cov tsos: Yellow solid

Kev Ntsuas: ≥99.0%

Qhov ceev: 1.281 g / cm3

Boiling Point: 625.248 ℃ ntawm 760 mmHg

Flash Point: 331.938 ℃

Cia kub: Khaws rau hauv qhov chaw tsaus, kaw hauv qhuav, 2-8 ℃

Vapor Siab: 0.0 ± 1.8 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.649

Cov ntaub ntawv kev nyab xeeb:

HS Code: 2933990090

Rucaparib (AG 014699) yog PARP inhibitor raug soj ntsuam raws li tus neeg sawv cev tiv thaiv kab mob cancer. Rucaparib yog thawj-hauv-chav tsev kho mob cov neeg sib tw tsom rau DNA kho enzyme poly-ADPribose polymerase-1 (PARP-1), thiab yog thawj zaug ua ke ua ib feem ntawm kev sib koom tes ntawm cov kws tshawb fawb ua haujlwm hauv Northern Institute of Cancer Research thiab Medical School of Newcastle. University, nrog rau Agouron Pharmaceuticals (San Diego). Nws yog tsim los ntawm Clovis Oncology.

Rucaparib inhibits" kev sib cog lus ntawm cov leeg leeg leeg, nrog rau cov qog nqaij hlav ntawm cov neeg mob qog noj ntshav. Nws kuj txo cov kev tsiv teb tsaws ntawm qee cov qog nqaij hlav thiab cov hlwb ib txwm nyob hauv kab lis kev cai." Nws tuaj yeem noj hauv qhov ncauj hauv daim ntawv ntsiav tshuaj.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom raws li patent muaj rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.

Cim npe nrov: rucaparib cas 283173-50-2, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

• Tug: 1-Butyl-3-methylimidazolium Chloride CAS 79917-90-1
• Tom ntej: Tom ntej: 5-Fluoro-2-methylbenzoic Acid CAS 33184-16-6